February 04, 2020
The pharmaceutical industry is currently experiencing a major development boost as a result of the digital transformation. Sellers of pharmaceuticals are increasingly offering their products and services online and via other communication channels. Patients receive the information they need quickly and can compare offers and prices and choose the right service for them. Digitalization also opens up opportunities for new therapeutic approaches, for therapy selection and for more personalized medicine. Artificial intelligence will change the processes of drug development in the future and have an impact on data management. For companies, strategic and digital orientation will become a decisive competitive factor. This book provides an overview of current trends, developments and the markets of the future in the pharmaceutical industry and related areas.
From Data to Vial: The impact of vertical IT integration on the success of CDMOs
Page 249 – 253
Status quo: data silos and media disruptions
Page 245 – 246
Vertical IT integration as a game changer
Page 249 – 253
Prof. Dr. Mario A. Pfannstiel is Professor of Business Administration in Healthcare – in particular innovative services and services and a member of the Institute for Networked Health at Neu-Ulm University of Applied Sciences.
Prof. Dr. Patrick Da-Cruz is Professor of Health Management at Neu-Ulm University of Applied Sciences, where he is also a member of the Institute for Networked Health and head of the MBA program Leadership and Management in Healthcare.
Prof. Dr. Erik Rederer is Professor of Business Administration with a focus on Corporate Finance and Director of Studies. He is a member of the Institute for Networked Health at Neu-Ulm University of Applied Sciences.
Publisher: Springer Gabler; 1st ed. 2020 Edition (February 3, 2020)
Language: German
Number of pages in the print edition: 577 pages